Akeso & Company Limited
Akeso & Company Limited, headquartered in Great Britain, is a prominent player in the healthcare and pharmaceutical industry. Founded in 2015, the company has rapidly established itself as a leader in innovative medical solutions, focusing on the development and distribution of advanced healthcare products. With a strong operational presence across Europe and beyond, Akeso & Company Limited offers a diverse range of services, including drug development, clinical trials, and regulatory consulting. Their commitment to quality and innovation sets them apart, ensuring that they meet the evolving needs of healthcare providers and patients alike. Recognised for their excellence, Akeso has achieved significant milestones, including partnerships with leading healthcare organisations and contributions to groundbreaking research. Their unique approach to product development and dedication to improving patient outcomes solidify their position as a trusted name in the industry.
DitchCarbon Score
How does Akeso & Company Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Akeso & Company Limited's score of 3 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Akeso & Company Limited's reported carbon emissions
In 2021, Akeso & Company Limited reported total carbon emissions of approximately 85,370 kg CO2e. This figure includes 200 kg CO2e from Scope 2 emissions, while Scope 1 emissions were recorded at 0 kg CO2e, and Scope 3 emissions accounted for about 85,170 kg CO2e. Comparatively, in 2019, the company's total emissions were about 116,460 kg CO2e, with Scope 2 emissions at 610 kg CO2e and Scope 3 emissions at approximately 115,850 kg CO2e. This indicates a significant reduction in total emissions over the two years, showcasing a commitment to lowering their carbon footprint. Despite these reductions, Akeso & Company Limited has not publicly disclosed specific reduction targets or initiatives related to the Science Based Targets initiative (SBTi) or other climate pledges. The absence of formal targets suggests that while the company is making progress in reducing emissions, there may be opportunities for further commitment to structured climate action.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2019 | 2021 | |
|---|---|---|
| Scope 1 | - | - |
| Scope 2 | 610 | 000 |
| Scope 3 | 115,850 | 00,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Akeso & Company Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
